Artax Biopharma Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Artax Biopharma Inc.
Quantité totale PI 19
Rang # Quantité totale PI 80 379
Note d'activité PI 1,7/5.0    8
Rang # Activité PI 115 187
Classe Nice dominante Services scientifiques, technolo...

Brevets

Marques

8 2
3 0
6 0
0
 
Dernier brevet 2025 - Chromene derivatives as inhibito...
Premier brevet 2014 - Chromene derivatives as inhibito...
Dernière marque 2020 - ARTAX
Première marque 2020 - ARTAX

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Chromene derivatives as inhibitors of tcr-nck interaction. The present invention provides compou...
2024 Invention Solid and salt forms of tcr-nck modulators and uses thereof. The present invention provides solid...
2023 Invention Chromene derivatives as inhibitors of tcr-nck interaction. The present invention provides compoun...
2020 P/S Research and development in the pharmaceutical and biotechnology fields
2018 Invention Aryl-piperidine derivatives. 3, X, Cz, and Cy is that specified in the description, for use as in...
Invention Aza-dihydro-acridone derivatives. 3 is that specified in the description, to be used as T cells p...
Invention Aza-dihydro-acridone derivatives. Aza-dihydro-acridone derivatives of formula I, wherein the mean...
Invention Aryl-piperidine derivatives. An aryl-piperidine derivative of formula I, wherein the meaning of R...
2014 Invention Chromene derivatives as inhibitors of tcr-nck interaction. The present invention relates to a gro...
Invention Chromene derivatives substituted by alkoxide as inhibitors of the tcr-nck interaction. The presen...
Invention Chromene derivatives as inhibitors of tcr-nck interaction. The invention relates to a group of co...
Invention Chromene derivatives as inhibitors of the tcr-nck interaction. The invention relates to a group o...